S. Mudivarthy

909 citations
4 papers · 734 · 1 hit paper · h-index 3

Impact in

    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Hematology top 5%
    • Autoimmune and Inflammatory Disorders Research

Papers in

    • Spondyloarthritis Studies and Treatments 4
    • Rheumatoid Arthritis Research and Therapies 1
    • Autoimmune and Inflammatory Disorders Research 1

S. Mudivarthy

4 papers receiving 700 citations

S. Mudivarthy's Hit Papers

Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study 2009 · 485 citations
4850+5+11Years since publication100200300400

Peers

S. Mudivarthy
Comparison fields: 5 of 39
  • Rheumatology 567
  • Hematology 190
  • Immunology 324
  • Dermatology 54
  • Complementary and Manual Therapy 4
Replace Elinor Mody with:
Elinor Mody United States
Dafna Gladman Canada
Jason Coarse United States
B. Kroegler Italy
Benjamin Porter-Brown United Kingdom
Sharon Jones United Kingdom
Maxime Dougados France
S. Li United States
Sabrina Rebello United States
E.J. Bodar Netherlands
S. Mudivarthy relative to Elinor Mody United States Elinor Mody's profile →
Citations per field
00.5×2.5×
Elinor Mody · 1×
Citations per year

Countries citing papers authored by S. Mudivarthy

Since Specialization
Citations

This map shows the geographic impact of S. Mudivarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Mudivarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Mudivarthy more than expected).

Fields of papers citing papers by S. Mudivarthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Mudivarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Mudivarthy. The network helps show where S. Mudivarthy may publish in the future.

Co-authors

The 19 scholars most cited alongside S. Mudivarthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Mudivarthy Line = papers co-authored together S. Mudivarthy links everyone, so they are left out of the graph.

All Works

4 of 4 papers shown
#Work
1
Golimumab, a new human tumor necrosis factor α antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty‐four–week efficacy and safety results of a randomized, placebo‐controlled study
Hit paper breakdown →
2009485
2 2012172
3 201276
4 20111

About S. Mudivarthy

S. Mudivarthy is a scholar working on Rheumatology, Hematology, Infectious Diseases, Organic Chemistry and Surgery, having authored 4 papers that have together received 734 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (4 papers), Autoimmune and Inflammatory Disorders Research (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Rheumatology (567 citations), Hematology (190 citations), Immunology (324 citations), Dermatology (54 citations) and Complementary and Manual Therapy (4 citations). S. Mudivarthy has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Philip J. Mease, Gerald G. Krueger, M. Mack, Anna Beutler, Dafna D. Gladman, Iain B. McInnes, Julie Zrubek, Juan J. Gómez‐Reino, Kim Papp and Arthur Kavanaugh. Their work appears in journals such as Annals of the Rheumatic Diseases, Value in Health and Arthritis & Rheumatism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact